Evercore ISI analyst Liisa Bayko maintained a Buy rating on Vertex Pharmaceuticals (VRTX – Research Report) today and set a price target ...

Wells Fargo analyst Mohit Bansal has maintained their bullish stance on VRTX stock, giving a Buy rating yesterday. Mohit Bansal has given his ...

Shares of Vertex Pharmaceuticals Inc. VRTX slipped 3.15% to $483.00 Friday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index SPX rising 0.40% ...

Shares of Vertex Pharmaceuticals Inc. VRTX inched 0.61% higher to $487.25 Wednesday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index SPX ...

New Century Financial Group LLC lessened its holdings in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Free Report) by 25.1% during the 3rd quarter, according to its most recent disclosure with ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

These pharmaceutical stocks have attractive dividends and valuation upside.

Vertex Pharmaceuticals Inc (VRTX) reports robust revenue growth and raises guidance, while addressing acquisition-related ...

Vertex Pharmaceuticals has outpaced the broader ... of the author and do not necessarily reflect those of Nasdaq, Inc. With headquarters in the heart of Chicago's financial district, Barchart ...

Barlow Wealth Partners Inc. grew its stake in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Free Report) by ...

Over the last 7 days, the United States market has risen by 1.2%, contributing to a substantial increase of 35% over the past ...